Literature DB >> 19619263

The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.

Thean Y Tan1, Ai L Tan, Nancy W S Tee, Lily S Y Ng, Chloe W J Chee.   

Abstract

Various studies have documented a shift in species distribution in Candida bloodstream infections (BSI), but there are little data from Southeast Asia. This study was performed to determine the species epidemiology and antifungal susceptibilities of Candida species BSI in Singapore. Candida spp. from BSI were collected from a tertiary and secondary referral hospital, and an obstetrics/paediatric hospital over a 3-year period. The most common isolates were Candida albicans (36%), Candida tropicalis (27%), Candida glabrata (16%) and Candida parapsilosis (16%). Candida parapsilosis and C. albicans were predominant in the paediatric hospital, and C. albicans and C. tropicalis predominant in the other two institutions. Candida tropicalis temporarily replaced C. albicans as the predominant strain from BSI in 2006. Overall, 87.3% of Candida isolates were susceptible to fluconazole, and 10.4% classified as susceptible-dose-dependent. Fluconazole resistance was detected in C. tropicalis (3.6%), C. parapsilosis (2.1%) and C. glabrata (4.0%). Candida albicans is the predominant species isolated from BSI in Singapore. However, non-albicans species accounted for nearly two-thirds of all cases of candidaemia and the relative increase in C. tropicalis infections deserves further investigation. Resistance to fluconazole was uncommon.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19619263     DOI: 10.1111/j.1439-0507.2009.01746.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  12 in total

1.  In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Authors:  Tsun Sheng N Ku; Stella M Bernardo; Samuel A Lee
Journal:  J Med Microbiol       Date:  2011-06-23       Impact factor: 2.472

2.  Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.

Authors:  J Q Farooqi; K Jabeen; N Saeed; N Iqbal; B Malik; S R Lockhart; A Zafar; M E Brandt; R Hasan
Journal:  J Med Microbiol       Date:  2012-10-25       Impact factor: 2.472

3.  Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt.

Authors:  Mohammed A El-Kholy; Ghada F Helaly; Ebtisam F El Ghazzawi; Gamal El-Sawaf; Sherine M Shawky
Journal:  J Fungi (Basel)       Date:  2021-04-29

Review 4.  Epidemiology and risk factors for invasive candidiasis.

Authors:  Nur Yapar
Journal:  Ther Clin Risk Manag       Date:  2014-02-13       Impact factor: 2.423

5.  Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes.

Authors:  Jocelyn Qi-Min Teo; Samuel Rocky Candra; Shannon Jing-Yi Lee; Shannon Yu-Hng Chia; Hui Leck; Ai-Ling Tan; Hui-Peng Neo; Kenneth Wei-Liang Leow; Yiying Cai; Pui Lai Rachel Ee; Tze-Peng Lim; Winnie Lee; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Resist Infect Control       Date:  2017-03-11       Impact factor: 4.887

Review 6.  Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.

Authors:  Siang Fei Yeoh; Tae Jin Lee; Ka Lip Chew; Stephen Lin; Dennis Yeo; Sajita Setia
Journal:  Infect Drug Resist       Date:  2018-05-30       Impact factor: 4.003

7.  Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells.

Authors:  María J Navarro-Arias; Marco J Hernández-Chávez; Laura C García-Carnero; Diana G Amezcua-Hernández; Nancy E Lozoya-Pérez; Eine Estrada-Mata; Iván Martínez-Duncker; Bernardo Franco; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2019-04-08       Impact factor: 4.003

8.  In Vitro Anti-Biofilm Activities of Citral and Thymol Against Candida Tropicalis.

Authors:  Apurva Chatrath; Rashmi Gangwar; Poonam Kumari; Ramasare Prasad
Journal:  J Fungi (Basel)       Date:  2019-02-03

Review 9.  Molecular fingerprints to identify Candida species.

Authors:  Claudia Spampinato; Darío Leonardi
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411

10.  In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs.

Authors:  Kamiar Zomorodian; Azadeh Bandegani; Hossein Mirhendi; Keyvan Pakshir; Navvab Alinejhad; Ali Poostforoush Fard
Journal:  Jundishapur J Microbiol       Date:  2016-02-20       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.